antimycin a has been researched along with Mesothelioma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, X; Littlejohn, J; Morgan, CD; Rodarte, C; Smythe, WR; Zhang, L | 1 |
1 trial(s) available for antimycin a and Mesothelioma
| Article | Year |
|---|---|
Bcl2/bcl-xL inhibitor engenders apoptosis and increases chemosensitivity in mesothelioma.
Topics: Antimycin A; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; bcl-X Protein; Cell Line, Tumor; Genes, bcl-2; Humans; In Vitro Techniques; Mesothelioma; Pleural Neoplasms | 2007 |